Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.429,24
0,66%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Rezolute Inc (RZLT) Rezolute Inc (RZLT) Notizie

Rezolute Inc

RZLT
4,91
0,05 (1,03%)
23 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/11/202400:59EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202415:35EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202422:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:38EDGAR2Form 8-K - Current report
07/11/202422:05GLOBERezolute Reports First Quarter Fiscal 2025 Financial Results..
05/11/202414:00GLOBERezolute to Participate in Upcoming Investor Conferences
21/10/202422:43EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/10/202422:41EDGAR2Form DEF 14A - Other definitive proxy statements
10/10/202422:40EDGAR2Form PRE 14A - Other preliminary proxy statements
24/9/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202422:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
19/9/202422:09EDGAR2Form 8-K - Current report
19/9/202422:05GLOBERezolute Reports Fourth Quarter and Full Year Fiscal 2024..
09/9/202413:30EDGAR2Form 8-K - Current report
09/9/202413:30GLOBEFDA Lifts Partial Clinical Holds on RZ358 for the Treatment..
27/8/202414:00GLOBERezolute to Participate in Upcoming Investor Conferences
15/8/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
10/8/202403:47EDGAR2Form S-3/A - Registration statement under Securities Act of..
05/8/202423:00EDGAR2Form S-3 - Registration statement under Securities Act of..
05/8/202413:30EDGAR2Form 8-K - Current report
05/8/202413:30GLOBERezolute Announces FDA Clearance of IND Application for..
31/7/202414:00GLOBERezolute to Participate in the BTIG Virtual Biotechnology..
27/6/202414:00GLOBERezolute Announces Exercise of Underwriters’ Option to..
24/6/202414:00GLOBERezolute Announces Closing of Public Offering with..
14/6/202422:51EDGAR2Form 8-K - Current report
14/6/202422:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/6/202418:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202405:30GLOBERezolute Announces Pricing of Public Offering of $60 Million..
13/6/202423:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/6/202422:01GLOBERezolute Announces Proposed Public Offering of Common Stock..
30/5/202414:00GLOBERezolute to Participate in the Jefferies Global Healthcare..
28/5/202420:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202420:37EDGAR2Form 8-K - Current report
21/5/202422:05GLOBERezolute Reports Positive Topline Results from Phase 2 Proof..
17/5/202422:21EDGAR2Form 8-K - Current report
15/5/202422:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202422:05GLOBERezolute Reports Third Quarter Fiscal 2024 Financial Results..
23/4/202414:00GLOBEPhase 2 RIZE Study Sub-Analyses to be Presented at the 2024..
11/3/202422:03EDGAR2Form 8-K - Current report
11/3/202415:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202413:30GLOBERezolute Reports Validation of the Potential Use of RZ358..
27/2/202414:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202423:00EDGAR2Form 8-K - Current report
21/2/202417:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/2/202422:10EDGAR2Form 8-K - Current report
13/2/202422:05GLOBERezolute Reports Second Quarter Fiscal 2024 Results and..
29/1/202423:15EDGAR2Form 8-K - Current report
25/1/202418:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 4,78 Min: 4,68 Max: 4,99
Chiusura: 4,86

La tua Cronologia

NASDAQ
RZLT
Rezolute
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network